Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to Borewad et al. Comment on "Rao et al. The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis. <i>Cancers</i> 2025, <i>17</i>, 862".

Cancers·2026
Same author

Gingipain-Mediated Matrix Metalloproteinase-8 and -9 Activation in Oral Rinse Samples from Patients with Cancer: A Cross-Sectional Study.

Dentistry journal·2026
Same author

The Prognostic Significance of Tertiary Lymphoid Structures in Head and Neck Cancers: A Systematic Review and Meta-Analysis.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2026
Same author

Treatment-Related Adverse Event Claims in Otorhinolaryngology-Head and Neck Surgery: A Nationwide Finnish Review (2012-2023).

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2026
Same author

Absence of DNA viruses in ameloblastomas.

European journal of oral sciences·2026
Same author

DNA Virus Detection in Olfactory Neuroblastomas Using Targeted Enrichment NGS.

Neuropathology : official journal of the Japanese Society of Neuropathology·2026

Related Experiment Video

Updated: Jun 23, 2025

3D Printing of Preclinical X-ray Computed Tomographic Data Sets
11:06

3D Printing of Preclinical X-ray Computed Tomographic Data Sets

Published on: March 22, 2013

40.5K

Core Legal Challenges for Medical 3D Printing in the EU.

Ante B V Pettersson1,2, Rosa Maria Ballardini3, Marc Mimler4

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, FI-00029 HUS, Helsinki, Finland.

Healthcare (Basel, Switzerland)
|June 19, 2024
PubMed
Summary
This summary is machine-generated.

Unclear legislation hinders medical 3D printing adoption. Analysis reveals EU regulations are inflexible, creating legal uncertainties that stifle innovation despite patient safety needs. Adaptive laws are crucial for progress.

Keywords:
3D printingadditive manufacturinglegal issueslegislationmedicalmedicineregulation

More Related Videos

Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

7.1K
Voxel Printing Anatomy: Design and Fabrication of Realistic, Presurgical Planning Models through Bitmap Printing
11:36

Voxel Printing Anatomy: Design and Fabrication of Realistic, Presurgical Planning Models through Bitmap Printing

Published on: February 9, 2022

2.8K

Related Experiment Videos

Last Updated: Jun 23, 2025

3D Printing of Preclinical X-ray Computed Tomographic Data Sets
11:06

3D Printing of Preclinical X-ray Computed Tomographic Data Sets

Published on: March 22, 2013

40.5K
Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

7.1K
Voxel Printing Anatomy: Design and Fabrication of Realistic, Presurgical Planning Models through Bitmap Printing
11:36

Voxel Printing Anatomy: Design and Fabrication of Realistic, Presurgical Planning Models through Bitmap Printing

Published on: February 9, 2022

2.8K

Area of Science:

  • Medical Technology Law
  • Regulatory Science

Background:

  • 3D printing is increasingly used in medicine, but its wider adoption faces regulatory hurdles.
  • Existing legislation presents challenges for medical 3D printing implementation.

Purpose of the Study:

  • To analyze European Union (EU) legislation and case law impacting medical 3D printing.
  • To identify legal gaps and uncertainties in key areas: pre-market approval, post-market liability, intellectual property, and data protection.

Main Methods:

  • Legal doctrinal study and legal informatics were employed.
  • Analysis focused on EU legislation and relevant case law concerning medical 3D printing (excluding bioprinting/pharmacoprinting).

Main Results:

  • Significant gaps and uncertainties were identified within the current EU regulatory framework.
  • The existing EU regulatory approach is characterized as limiting, inflexible, and overly cautious.
  • Both legal ambiguities and overregulation were found to impede innovation in medical 3D printing.

Conclusions:

  • The current EU regulatory framework for medical 3D printing requires adaptation.
  • More flexible and adaptive legislation is necessary to foster innovation and improve patient outcomes.
  • Balancing patient safety with the need for continuous innovation is essential.